Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-866
Closed -$25.5K 819
2022
Q1
$25.5K Buy
866
+85
+11% +$2.59K 0.01% 642
2021
Q4
$20.8K Buy
781
+93
+14% +$2.58K 0.01% 572
2021
Q3
$18.8K Hold
688
﹤0.01% 683
2021
Q2
$17.6K Buy
+688
New +$18K ﹤0.01% 717
2017
Q3
Sell
-44,420
Closed -$1.41M 581
2017
Q2
$1.36M Buy
+44,420
New +$1.38M 0.29% 83
2016
Q3
Sell
-6,546
Closed -$196K 632
2016
Q2
$196K Buy
+6,546
New +$176K 0.03% 201

Other funds holding BP

Exane Derivatives's BP Position: Q2 2022 in Review

Exane Derivatives sold out of BP (BP) in Q2 2022, closing a stake of 866 shares — an estimated $25.5K sold.

Exane Derivatives first reported a position in BP in Q2 2016 and held it in 6 quarters. The position peaked at $1.36M in Q2 2017. 1,007 funds tracked by Wall St. Rank hold BP as of Q2 2022.

  • Exane Derivatives reported no remaining BP position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 866 BP shares in Q2 2022, an estimated $25.5K.
  • Exane Derivatives first reported a position in BP in Q2 2016 and held it in 6 quarters.
  • Exane Derivatives's BP position peaked at $1.36M in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held BP as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.